Racial Differences in Alzheimer’s Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2

BACKGROUND: African Americans are at increased risk for Alzheimer’s disease (AD) but barriers to optimal clinical care are unclear. OBJECTIVE: To comprehensively evaluate potential racial differences in the diagnosis and treatment of AD in an academic medical center. METHODS: We used the clinical in...

Descripción completa

Detalles Bibliográficos
Autores principales: Murchison, Charles F., Kennedy, Richard E., McConathy, Jonathan E., Roberson, Erik D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902957/
https://www.ncbi.nlm.nih.gov/pubmed/33337364
http://dx.doi.org/10.3233/JAD-200796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902957/
https://www.ncbi.nlm.nih.gov/pubmed/33337364
http://dx.doi.org/10.3233/JAD-200796

Ejemplares similares